API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214831
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214921
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214924
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214875
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214848
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214918
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214501
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214875
https://www.pharmatimes.com/news/positive_mhra_decision_for_briviact_1450496
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214848
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214748
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214922
https://www.prnewswire.com/news-releases/ucb-announces-briviact-brivaracetam-cv-now-fda-approved-to-treat-partial-onset-seizures-in-pediatric-patients-one-month-of-age-and-older-301364625.html
https://www.ndtv.com/business/lupin-receives-tentative-nod-for-anti-seizure-drug-stock-edges-higher-2512427#:~:text=Lupin%20has%20received%20tentative%20nod,its%20plant%20located%20at%20Nagpur.
https://www.business-standard.com/article/news-cm/zydus-cadila-receives-usfda-tentative-approval-for-brivaracetam-tablets-121061500261_1.html#:~:text=Zydus%20Cadila%20has%20received%20tentative,onset%20of%20seizures%20(epilepsy).
https://www.business-standard.com/article/health/zydus-cadila-gets-usfda-tentative-nod-for-epilepsy-treatment-drug-121061400259_1.html
https://www.expresspharma.in/market-pharma/natco-launches-brivaracetam-tablets-in-india/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-launches-epilepsy-treatment-drug-brivaracetam-in-india/articleshow/81227179.cms
https://www.newswire.ca/news-releases/health-canada-approves-brivlera-r-brivaracetam-to-treat-partial-onset-seizures-in-pediatric-epilepsy-patients-868605074.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-briviact-205836-brivaracetam-10-mg-25-mg-50-mg-75-mg-and-100-mg-1594795917.pdf
https://www.prnewswire.com/news-releases/ucb-announces-new-data-from-its-epilepsy-portfolio-presented-on-the-american-academy-of-neurology-virtual-platform-301083059.html
https://www.prnewswire.com/news-releases/ucb-presents-new-data-demonstrating-commitment-to-epilepsy-at-2019-american-epilepsy-society-meeting-300969719.html
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
http://www.pmlive.com/pharma_news/ucbs_antiepileptic_drug_gains_new_us_indication_1205968
http://www.prnewswire.com/news-releases/new-indication-for-briviact-brivaracetam-ucbs-newest-antiepileptic-drug-approved-by-fda-as-monotherapy-treatment-of-partial-onset-seizures-in-adults-300520242.html